Status:
COMPLETED
Comparing the Effects of Smoked and Oral Marijuana in Individuals With HIV/AIDS
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Conditions:
HIV Infections
Eligibility:
All Genders
21-50 years
Phase:
PHASE1
PHASE2
Brief Summary
Smoked marijuana (MJ) and dronabinol (also known as THC or by the trade name Marinol) are used to increase appetite, food intake, and weight in patients with HIV who experience unintended weight loss....
Detailed Description
Little is known about the efficacy and tolerability of oral THC versus smoked MJ in a clinically relevant population. Additionally, it is not clear how THC's effects vary as a function of the duration...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- HIV infected
- Smoke marijuana
- Taking HIV medications
- Exclusion criteria
- Naive marijuana smokers
- People with history of respiratory/pulmonary disease
Exclusion
Key Trial Info
Start Date :
December 1 2001
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2005
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00079560
Start Date
December 1 2001
End Date
August 1 2005
Last Update
January 11 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
New York State Psychiatric Institute
New York, New York, United States, 10032